Cardiovascular health—Resting heart rate (beats per minute) trajectories over phase 1 (baseline), phase 2 (intervention) and phase 3 (follow-up monitoring); (n = 102 participants).... by Kelly K. O’Brien (4954600)

Subjects:

Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure. by Andrew T. Marshall (10159199)

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

DENV infection significantly changes intracellular fatty acid levels. by Li Xu (108702)

Summary of significance levels for comparison of surgical segment ROM between different test groups. by Jia Zhu (135506)

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

Decreasing laminin levels in BCs does not affect their migration. by Ester Molina López (16462735)

Autophagy significantly influences the apoptotic levels of RGCs in glaucomatous mouse eyes. by Hongmei Qian (538647)

Subjects:

Top 10 vegetable varieties grown one year after the intervention phase-out. by Killian N. Mlalama (13833459)

Subjects:

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)

Association between intervention phases and FCHV counseling among postpartum mothers delivering in the two hospitals. by Rolina Dhital (6660908)

Subjects:

Association between intervention phases and knowledge on key messages of postpartum family planning among FCHVs. by Rolina Dhital (6660908)

Subjects:

Significantly associated microbial species between the pre- and post-eradication states (at a significance level <i>p</i><0.05). by Dita Gudra (4439767)

Subjects:

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

Primary outcome—V̇O₂peak (ml/kg/min) trajectories over phase 1 (baseline), phase 2 (intervention) and phase 3 (follow-up monitoring); (n = 100 participants). by Kelly K. O’Brien (4954600)

Subjects:

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Associations between decreases in serum UA levels and functional outcomes at 3 months. by Kuniyuki Nakamura (13040299)

Subjects:

Associations between decreases in serum UA levels and neurological outcomes during hospitalization. by Kuniyuki Nakamura (13040299)

Subjects:

Forest plot of pain score comparing the combined intervention (NNS and sucrose) with applying NNS alone in the recovery phase. by Qiaohong Li (1678627)

Forest plot of pain score comparing the combined intervention (NNS and sucrose) with applying sucrose alone in recovery phase. by Qiaohong Li (1678627)